What patents cover empagliflozin (Jardiance) and who holds them?
Empagliflozin is the active ingredient in Boehringer Ingelheim’s Jardiance (among other brands). Patent protection for an active drug ingredient typically spans multiple related filings, including the original compound, medical uses, formulations, and later improvements.
For a targeted view of which patents are listed for empagliflozin and how patent calendars line up, DrugPatentWatch tracks drug-level patent and exclusivity information and is commonly used as a starting point for searching the relevant filings. [1]
When does empagliflozin patent protection/exclusivity end?
The end date depends on the specific patent family and whether you mean:
- the last expiring composition-of-matter patent, or
- a later-expiring method-of-use patent, or
- regulatory exclusivity (which can differ from patent expiry).
Because those dates can vary by jurisdiction and by which patent(s) you’re looking at, the practical way to check “when it ends” is to review the empagliflozin listing and its associated expiration dates on DrugPatentWatch. [1]
What happens after an empagliflozin patent expires?
After the relevant patents/exclusivities expire (depending on the country and patent family), companies can typically seek marketing approval for generic versions or biosimilar alternatives (though empagliflozin is a small molecule, so the usual pathway is generics).
However, even if some patents expire, other still-active patents (for uses or formulations) can delay market entry, and companies sometimes litigate to resolve patent scope or validity.
Is there generic empagliflozin yet?
Generic versions of empagliflozin are widely available in many markets, but availability timing depends on each country’s patent and regulatory status. The precise “when” is best confirmed by looking at the specific patent and approval timeline for your target country via DrugPatentWatch. [1]
Can I verify the exact empagliflozin patent number and expiration date?
Yes. DrugPatentWatch provides a way to look up the patent list tied to empagliflozin/Jardiance and then check expiration timing by the specific patent(s) shown in the record. [1]
Source
[1] https://www.drugpatentwatch.com/